Introduction
Epilepsy and seizures may have a profound effect on cardiac function. In patients with seizures, epileptic discharges are thought to propagate to the central autonomic network and change or disturb the normal autonomic control of vital cardiac functions. Typical cardiovascular manifestations of epilepsy include alterations in heart rate and rhythm, blood pressure, and electrocardiogram. 1 It is well known that patients with epilepsy have an increased risk for sudden unexpected death (SUDEP). The risk of SUDEP is increased 24 2 -to 40 3 -fold in the epileptic population compared to the general population. The exact mechanism of SUDEP is not completely understood however, it is most likely multifactorial. The most important risk factor for SUDEP is the frequency of generalized tonic-clonic seizures. 4 Seizure-related cardiac dysfunction is thought to be one important mechanism of SUDEP. Thus, alterations in cardiac functions in epileptic patients have become an issue of increasing interest. Left ventricular diastolic dysfunction (LVDD) is common in cardiac disease and contributes to the development of heart failure. Approximately half of the patients with newly diagnosed heart failure have normal or near normal global ejection fractions. These patients have been identified to have diastolic heart failure or heart failure with preserved ejection fraction (HFPEF). 5 LVDD is one of the principal causes of HFPEF. 6 A recent review reported a LVDD prevalence of 27.3% in the general population. 7 The ''gold standard'' in evaluating LV diastolic functions is the measurement of LV filling pressures. However, this method is invasive and not practical. Echocardiography may be used to noninvasively evaluate both systolic and diastolic cardiac functions. 8 Doppler studies are the preferred method to evaluate LVDD. The parameters measured by traditional mitral flow Doppler studies include E wave velocity, A wave velocity, E wave deceleration time (DT), isovolumetric relaxation time (IVRT), and the E/A ratio. The data obtained using this method are preload dependent and exhibit a lower accuracy. Within the last two decades, tissue Doppler imaging (TDI) has been developed to enhance the accuracy of diastolic heart function analyses. 9 TDI measures the diastolic and systolic velocities of the ventricular walls and mitral annulus, and is less affected by loading conditions. 10 The mitral annulus velocity as determined by TDI is a relatively preload independent variable and is superior to conventional mitral Doppler indices. 11 These parameters may be used to estimate the LV filling pressures. 12 Thus, TDI is currently used worldwide to evaluate LV diastolic function. 13 The ratio of the pulsed Doppler mitral E wave velocity to tissue-Doppler-derived peak early diastolic velocity of the mitral annulus movement (E/e 0 ) correlates with the LV filling pressures. 8 The European Society of Cardiology recommends using the Doppler echocardiographic index as a first step in the diagnosis of HFPEF. 5 The aim of this study was to investigate LV diastolic function using TDI in patients with newly diagnosed and untreated primary generalized epilepsy (PGE).
Material and methods

Patients
In this single-center prospective study, patients with electroclinical or only clinical diagnosis of idiopathic generalized epilepsy (IGE), who had at least one electroencephalogram (EEG) available, were recruited consecutively among those who presented to the outpatient epilepsy clinic at Medical Faculty of Baskent University from 2007 through 2011. Thirty newly diagnosed and untreated PGE patients (14 females, mean age 27.60 AE 9.64 years) and 30 healthy age-and gender-matched control subjects (14 females, mean age 29.47 AE 6.89 years) were included in this study. The patient's medical history was obtained, and the physical and neurological examinations were performed by the same neurologist. Similarly, the same cardiologist performed cardiac examinations on the patients and interpreted their electrocardiograms.
The exclusion criteria included pregnancy, known coronary artery disease, impaired liver or renal function, hypertension, moderate or severe valvular heart disease, impaired left ventricular systolic function (ejection fraction < 50%), restrictive, hypertrophic, or dilated cardiomyopathies, congenital heart disease, respiratory diseases, diabetes mellitus, malignancy, smoking, excessive alcohol consumption, hyperlipidemia, history of previous cardiac surgery, severe mitral annular calcification, atrial fibrillation or other severe arrhythmias, the presence of permanent pacemakers or implantable defibrillators, any medication usage, and poor echocardiographic images.
The type of epilepsy was determined according to the guidelines of the International League Against Epilepsy and was based on a detailed medical history obtained from the patients and/or witnesses, physical and neurological examinations, EEGs, and neuroradiological findings. 14 In the remaining 13 patients, 6 patients had a bilateral diffuse epileptic activity disorder, 6 patients had bilateral diffuse paroxysmal discharges of theta and sharp waves, and one patient exhibited background rhythm irregularity formed by beta waves.
Echocardiography
All of the patients were examined during a seizure-free period of at least 24 h prior to the recordings, and none of the patients reported seizures during the recording periods. All of the included patients underwent an echocardiography with a commercially available standard ultrasound diagnostic system (Vivid 7, GE Vingmed, Horten, Norway) equipped with a 2.5-MHz phased-array transducer. The images were obtained in the left lateral decubitus position after 10 min of rest. All of the patients were evaluated by M-mode, two-dimensional, pulse-wave Doppler and TDI echocardiography. The diameters of the LV and left atrium, and the thicknesses of the interventricular septum and LV posterior wall were measured by the M-mode technique according to the recommendations of the American Society of Echocardiography. 15 The peak velocities of the early (E) and late (A) diastolic filling, DT, and IVRT were derived from Doppler recordings of the mitral valve inflow and aortic valve outflow. 16 For TDI, the filter setting was lowered, and the Nyquist limit was adjusted (range, 15-20 cm/s). The gain was minimized to allow for a clear tissue signal with minimal background noise. For TDI recordings from the apical window, a 5-mm sample volume was located at the septal and lateral sides of the mitral valve annulus in the 4-chamber view and at the anterobasal and inferior sites in the 2-chamber view. 16 Measurements were recorded with simultaneous electrocardiography at a sweep speed of 50-100 mm/s. The peak systolic velocity (s 0 ), early (e 0 ) and late (a 0 ) diastolic velocities, and e 0 /a 0 ratio were measured. The E/average e 0 ratio was calculated by dividing the transmitral E peak by the e 0 average from the 4 acquisition sites. The LVDD diagnosis and staging were performed according to the recommendations of the European Association of Echocardiography. 17 The LVDD was identified if the mitral annular septal e 0 velocity was lower than 8 cm/s, if the mitral annular lateral e 0 velocity was lower than 10 cm/s, and if the left atrium volume index was higher than 34 mL/m 2 . LVDD has three grades (I, II, and III). When the LVDD was detected, the grade was estimated using Doppler parameters, including the E/A ratio, DT, IVRT, and the E/ average e 0 ratio as well as ancillary techniques, if necessary. 17 The ejection fraction was calculated according to the Teicholz formula. 18 All of the echocardiographic studies were digitally recorded for off-line analysis. All of the measurements were averaged from three cardiac cycles to minimize the respiratory variability and were blindly performed by a single independent expert sonographer with 10 years of experience. This study was approved by the local Ethics Committee and all of the subjects gave their written informed consent. The study was conducted according to the Declaration of Helsinki.
Statistics
All of the statistical analyses were performed using the SPSS software package, version 9.0 for Windows (SPSS Inc., Chicago, IL, USA). The continuous variables were expressed as the mean AE SD and the categorical variables as numbers and percentages. The Kolmogoroff-Smirnoff test was used to determine whether the data were normally distributed. Differences between the independent groups were assessed using an unpaired t-test
Results
The demographic and echocardiographic data of the patient and control groups are presented in Table 1 . The age, gender, and body mass index were comparable between these two groups, and there were no statistically significant differences regarding left atrium diameter and left atrium volume index (p = 0.64 and p = 0.38, respectively). The interventricular septum and posterior wall thickness were similar between the two groups as well (p = 0.47 and p = 0.11, respectively). Although the LV end diastolic diameter and LV end diastolic volume were comparable (p = 0.075 and p = 0.098, respectively), the LV end systolic diameter and LV end systolic volume were statistically higher in the PGE patients (p < 0.001 for both parameters). The LV fractional shortening and ejection fraction were lower in the PGE patients when compared to the control group (p < 0.001 for both parameters). The E wave velocity, E/A ratio, DT and IVRT were significantly higher in the PGE group (p < 0.001, p < 0.001, p < 0.001, and p = 0.003, respectively). The average e 0 was indifferent between the groups (p = 0.055). The E/average e 0 , which is the most important noninvasive indicator of LV filling pressure, was significantly higher in the PGE patients (8.31 AE 2.78 vs. 6.95 AE 1.26 in controls, p = 0.018). One patient in each group was diagnosed with LVDD (3.3% for each group). Of those patients, the patient with PGE had a LVDD of grade III and the control subject had a LVDD of grade II. Epilepsy duration and seizure frequency showed no significant correlations with left ventricular ejection fraction and E/average e 0 ratio (for all, p > 0.05).
Discussion
Normal diastolic function enables normal LV filling at rest and during exercise without the abnormal elevation of LV filling pressures. LVDD may be the first pathological finding of an underlying cardiac disease. 7 It has been associated with an increased risk of cardiovascular events and death. 19 Elevated filling pressures are the main physiological consequence of diastolic dysfunction. 20 When assessing LV diastolic performance, the tissue Doppler is more reliable than the conventional Doppler because it is not as influenced by the loading conditions and the TDI measurements are more reproducible. 21 Diastolic abnormalities may be detected using TDI, even before the onset of hemodynamic abnormalities in subjects who have normal conventional echocardiography. 22 The E/e 0 ratio is the single best parameter to predict the mean LV filling pressures. 8 This ratio is proportional to LVDD severity. In this study, newly diagnosed PGE patients had a higher E/e 0 ratio compared to control subjects, which indicates increased LV filling pressures in PGE patients and thus impaired LV diastolic function. During ventricular diastole, the left atrium is directly exposed to the LV filling pressure. Thus, an increased left atrium size and volume may reflect the duration and severity of the diastolic dysfunction. 23 Similar findings in the left atrium diameter and left atrium volume index between both groups suggest that LVDD in PGE is not long-term or very severe. In this study, only one case in each group (3%) was diagnosed with LVDD upon examination in light of recent recommendations. This rate is lower than that of the general population. LVDD prevalence increases with age. Both the patients and control subjects have a younger mean age, and patients with disorders that may cause LVDD have been excluded from the study. These reasons may explain the lower LVDD rates in our study cohort. Another important finding in this study is the lower LV fractional shortening and ejection fraction values, which resulted from a statistically significant increase in the LV end systolic diameter and LV end systolic volume. The mean LV ejection fraction in PGE patients were higher than the normal threshold, which was 50%. Although this takes away from the clinical importance of this decrease in fractional shortening and ejection fraction, it is still an important indicator of adverse outcomes on LV systolic functions.
Lack of significant correlations between epilepsy duration and seizure frequency and LV systolic and diastolic dysfunction suggests that adverse cardiac effects detected in PGE patients may not be cumulative.
Taken together, the findings in this study revealed a statistically significant deterioration of LV systolic and diastolic functions in PGE: primary generalized epilepsy, BMI: body mass index, E: peak mitral inflow early velocity, A: peak mitral inflow late velocity, e 0 : peak early diastolic annular velocity.
a Non-parametric tests were used.
PGE patients. The cardiac effects of epilepsy have gained attention over the recent years, and these effects are thought to be multifactorial. In this regard, the LV systolic and diastolic functions may be affected by various pathophysiological mechanisms in epileptic patients.
Autonomic dysfunction
Autonomic dysfunction in epileptic patients may be one of the mechanisms responsible for cardiac effects. Cardiovascular autonomic neuropathy (CAN) results in abnormalities in heart rate control and vascular dynamics. Autonomic dysfunction has been noted in 56.3% of patients with chronic refractory epilepsy. 24 Resting diastolic dysfunction is independently associated with the abnormal heart rate recovery, which is a marker of autonomic dysfunction. 25 Autonomic abnormalities have also been identified in patients with HFPEF. 26, 27 The autonomic nervous system affects cardiac myocyte calcium handling, 28 and cardiac autonomic abnormalities are associated with diastolic dysfunction. 29 To the best of our knowledge, there have been no published studies evaluating the relationship between autonomic dysfunction and LV diastolic function in epileptic patients; however, there have been studies examining diabetic patients. One of the main theories for the cause of diabetic cardiomyopathy is CAN. 30 CAN is a common form of autonomic dysfunction in patients with diabetes mellitus. 31 Heart rate variability (HRV) is a mirror of neuronal influences on the cardiac pacemaker, which is an important function of the autonomic nervous system. The HRV was lower in patients with chronic refractory epilepsy, which potentially resulted from a parasympathetic or vagal reduction. 32 A low HRV can make patients more susceptible to tachyarrythmia. Patients with longlasting and multiple seizures are more prone to chronic dysfunction of autonomic cardiac control. In patients with newly diagnosed (median time 27 months) and untreated epilepsy, no differences were found in HRV. 33 In contrast, the autonomic functions of newly diagnosed epileptic patients were assessed with a heart rate recovery measurement used in another study and it was reported that increased heart rate recovery suggests of increased parasympathetic functions. 34 On the basis of the aforementioned data, we conclude that autonomic dysfunction may affect the LV functions in newly diagnosed PGE patients.
Vagus nerve
Heart failure is characterized by an autonomic imbalance with a withdrawal of vagal activity and increased sympathetic activity. 35 During the early stages of heart failure, increased beta adrenergic stimulation may be beneficial, but long-term stimulation causes increased myocyte apoptosis, fibrous tissue formation, and electrical instability, thereby resulting in impaired ventricular performance. 36 There have been case reports documenting temporary LV systolic dysfunction after seizures in epileptic patients with Tako Tsubo cardiomyopathy. These patients were characterized with normal coronaries, and thus excessive adrenergic discharge was thought to be responsible for the etiology. 37, 38 Vagus nerve stimulation has been shown to improve the quality of life in patients with symptomatic heart failure and increase ejection fraction. 39 Moreover, vagus nerve stimulation has been successfully applied for many years to treat drug-resistant epilepsy. 40 We suggest that the vagus nerve may mediate a common pathophysiological pathway between impaired LV functions and epilepsy.
Myocardial ischemia
Myocardial ischemia and related cardiac injuries may facilitate LV systolic and diastolic dysfunction in PGE patients. An increased heart rate has been observed during most seizures. 41 Epileptic seizures may cause excessive autonomic activation and may precede myocardial damage via sympathetic overstimulation or subendocardial ischemia. During the ictal and the immediate postictal period, 40% of the patients demonstrated ST segment depression in an electrocardiogram. 42 Alehan et al. reported elevated levels of brain natriuretic peptides and a cardiac-specific fraction of creatine kinase in patients with seizures, which are the first evidence of subtle cardiac dysfunction in epileptic patients. 43 
SUDEP
There is evidence for an increase in cardiac autonomic stimulation in patients with SUDEP. 44 It has been reported that there is cardiac ischemic damage, despite normal coronary arteries, in the post mortem examinations of SUDEP victims. 45 This may be due to repeated episodes of vasoconstriction and an increase in sympathetic activity. Myocardial fibrosis has already been reported in patients with SUDEP. 46 One of the causes of LV stiffening is myocardial fibrosis. 47 Myocardial fibrosis may also cause LV systolic and diastolic dysfunction in PGE patients.
Study limitations
This study has several limitations. Despite normal EEG examinations, the diagnosis of epilepsy was solely based on clinical history in 17 patients. The fact that interictal EEG cannot differentiate seizure types and different IGE syndromes makes clinical history a key element in making the correct diagnosis of epilepsy. More than 40% of patients with epilepsy may have one normal interictal EEG. Studies investigating the first and serial EEG findings in patients with distinct IGE syndromes suggest that antiepileptic treatment should be initiated based on clinical history. Otherwise, time elapsed for documenting typical EEG abnormalities can cause a significant delay in the treatment of patients with IGE. [48] [49] [50] Another limitation of our study may be the duration of EEG (15 min) at our center, which might have yielded a higher frequency of normal EEGs in these patients. In addition, psychological disturbances like anxiety and depression may affect the autonomic nervous system, resulting in alterations in cardiac functions. Use of special tests to uncover these conditions may have excluded patients having psychological disturbances, and thus eliminated this confounding effect.
Conclusion
The cardiac effects of epileptic seizures are thought to be temporary and benign, however, this study demonstrated that newly diagnosed PGE patients have impaired systolic and diastolic functions when compared to control subjects. Screening epileptic patients with traditional echocardiography and TDI may be useful to evaluate the effects of epilepsy on cardiac functions.
